RCAG
LLY icon

Rehmann Capital Advisory Group’s Eli Lilly LLY Stock Holding History

Rehmann Capital Advisory Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.65M Buy
5,059
+200
+4% +$203K 0.24% 72
2025
Q4 		$5.23M Buy
4,859
+126
+3% +$120K 0.27% 64
2025
Q3 		$3.61M Buy
4,733
+50
+1% +$37.2K 0.2% 87
2025
Q2 		$3.65M Sell
4,683
-166
-3% -$129K 0.22% 83
2025
Q1 		$4.01M Buy
4,849
+538
+12% +$448K 0.25% 79
2024
Q4 		$3.33M Sell
4,311
-46
-1% -$38.1K 0.21% 88
2024
Q3 		$3.71M Buy
4,357
+131
+3% +$118K 0.24% 82
2024
Q2 		$3.83M Buy
4,226
+254
+6% +$203K 0.27% 74
2024
Q1 		$3.09M Sell
3,972
-61
-2% -$43.4K 0.23% 82
2023
Q4 		$2.35M Buy
4,033
+527
+15% +$308K 0.19% 100
2023
Q3 		$1.88M Sell
3,506
-134
-4% -$69K 0.18% 102
2023
Q2 		$1.71M Sell
3,640
-156
-4% -$65.4K 0.15% 112
2023
Q1 		$1.3M Buy
3,796
+506
+15% +$171K 0.12% 150
2022
Q4 		$1.2M Sell
3,290
-46
-1% -$16.3K 0.12% 145
2022
Q3 		$1.08M Sell
3,336
-261
-7% -$82.7K 0.12% 151
2022
Q2 		$1.17M Buy
3,597
+138
+4% +$41.4K 0.13% 141
2022
Q1 		$991K Buy
3,459
+87
+3% +$22.4K 0.09% 192
2021
Q4 		$931K Sell
3,372
-63
-2% -$16K 0.09% 202
2021
Q3 		$795K Sell
3,435
-224
-6% -$55.3K 0.08% 227
2021
Q2 		$843K Sell
3,659
-118
-3% -$23.7K 0.08% 212
2021
Q1 		$705K Sell
3,777
-92
-2% -$18K 0.07% 226
2020
Q4 		$653K Sell
3,869
-795
-17% -$119K 0.07% 217
2020
Q3 		$690K Buy
4,664
+67
+1% +$10.4K 0.09% 196
2020
Q2 		$755K Buy
4,597
+1
+0% +$153 0.1% 176
2020
Q1 		$638K Buy
+4,596
New +$631K 0.1% 167
2019
Q3 		$468K Sell
4,186
-429
-9% -$47.8K 0.06% 175
2019
Q2 		$511K Sell
4,615
-73
-2% -$8.6K 0.06% 246
2019
Q1 		$608K Sell
4,688
-6,273
-57% -$763K 0.08% 185
2018
Q4 		$1.27M Sell
10,961
-106
-1% -$11.8K 0.19% 63
2018
Q3 		$1.19M Buy
11,067
+725
+7% +$72.5K 0.16% 107
2018
Q2 		$882K Buy
10,342
+1,509
+17% +$124K 0.13% 137
2018
Q1 		$683K Buy
8,833
+1,692
+24% +$136K 0.11% 155
2017
Q4 		$603K Sell
7,141
-35
-0.5% -$2.98K 0.1% 175
2017
Q3 		$614K Buy
7,176
+2,244
+45% +$184K 0.11% 164
2017
Q2 		$406K Sell
4,932
-94
-2% -$7.67K 0.08% 200
2017
Q1 		$423K Buy
5,026
+43
+0.9% +$3.44K 0.07% 212
2016
Q4 		$367K Sell
4,983
-125
-2% -$9.31K 0.07% 235
2016
Q3 		$410K Sell
5,108
-550
-10% -$44K 0.08% 206
2016
Q2 		$446K Buy
5,658
+241
+4% +$18.1K 0.08% 189
2016
Q1 		$390K Buy
5,417
+563
+12% +$42.6K 0.08% 205
2015
Q4 		$409K Buy
4,854
+978
+25% +$81.2K 0.09% 178
2015
Q3 		$324K Sell
3,876
-1,009
-21% -$85.2K 0.07% 206
2015
Q2 		$408K Buy
4,885
+12
+0.2% +$914 0.09% 179
2015
Q1 		$354K Buy
4,873
+1,291
+36% +$91.9K 0.08% 203
2014
Q4 		$247K Buy
3,582
+302
+9% +$20.4K 0.06% 270
2014
Q3 		$213K Buy
+3,280
New +$208K 0.05% 298

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Rehmann Capital Advisory Group's LLY Position: Q1 2026 in Review

Rehmann Capital Advisory Group increased its Eli Lilly (LLY) stake by 4.1% in Q1 2026, buying an estimated $203K and bringing the position to 5,059 shares worth $4.65M. The position accounts for 0.24% of the portfolio, ranked #72.

Rehmann Capital Advisory Group first reported a position in LLY in Q3 2014 and has held it in 46 quarters since. The position peaked at $5.23M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Rehmann Capital Advisory Group held 5,059 shares of Eli Lilly worth $4.65M as of Q1 2026.
  • Rehmann Capital Advisory Group bought 200 Eli Lilly shares in Q1 2026, an estimated $203K.
  • Eli Lilly made up 0.24% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #72 holding.
  • Rehmann Capital Advisory Group first reported a position in Eli Lilly in Q3 2014 and has held it in 46 quarters since.
  • Rehmann Capital Advisory Group's Eli Lilly position peaked at $5.23M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.